Paul McEwan

Paul McEwan

Chairman at seqWell, Inc.

Health Technology
Consumer Services
Commercial Services

Profile

Paul is a co–founder and currently serves as the Chief Scientific Officer of Kapa Biosystems, a company using protein evolution technology for the development of life science tools and kits.
Previously he co–founded both Agencourt Bioscience Corporation and Agencourt Personal Genomics.
Agencourt Bioscience was a market leader in the genomic services and DNA purification markets which was successfully sold to Beckman Coulter in 2005.
Agencourt Personal Genomics was acquired by Applied Biosystems and its technology was used as the basis for the SOLiDTM next–generation DNA sequencer.
Previous to these positions, Paul was a member of technology development group at the Whitehead/MIT Center for Genome Research where he developed automation and biochemical processes for the scale–up effort to sequence the Human Genome.
Paul holds a BS in Biology and Anthropology from Emory University.

Paul McEwan active positions

CompaniesPositionStart
Private Equity Investor 2005-12-31
Chairman -
Director/Board Member -
All active positions of Paul McEwan

Former positions of Paul McEwan

CompaniesPositionEnd
Founder 2018-11-30
Corporate Officer/Principal -
Director/Board Member -
Genome Research Group Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Paul McEwan's experience

Training of Paul McEwan

Emory University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Paul McEwan's experience

Connections

100 +

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies8

Health Technology

Commercial Services

Health Technology

Genome Research Group

Health Technology

Finance

Health Technology

Health Technology

Health Technology

See company connections